Rank 94 • MedTech & Devices
Precision Neuroscience
Develops high-resolution, modular cortical implants designed to map brain activity and restore function without damaging tissue.
Visit website- Signal Score
- 82.9
- Total raised
- $53M
- Stage
- Series B
- Founded
- 2021
- Headquarters
- New York, USA
- Region
- North America
Their signal
Precision Neuroscience offers a semi-invasive, high-channel-count alternative to penetrating BCIs. Led by industry veterans, its rapid clinical progress and modular architecture command high market valuation.
Signal Score 82.9editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.